Total Payments
$4,098
2024 Payments
$351.36
Companies
28
Transactions
246
Medicare Patients
2,385
Medicare Billing
$407,490
Payment Breakdown by Category
Food & Beverage$4,087 (99.7%)
Education$10.64 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,087 | 244 | 99.7% |
| Education | $10.64 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,021 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $538.01 | 41 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $365.98 | 26 | $0 (2019) |
| Novo Nordisk Inc | $265.34 | 19 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $257.28 | 30 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $247.41 | 12 | $0 (2021) |
| Allergan Inc. | $188.37 | 13 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $156.36 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $144.21 | 11 | $0 (2021) |
| Xeris Pharmaceuticals, Inc. | $138.86 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.36 | 11 | AstraZeneca Pharmaceuticals LP ($220.09) |
| 2023 | $501.33 | 17 | AstraZeneca Pharmaceuticals LP ($316.55) |
| 2022 | $252.90 | 11 | AstraZeneca Pharmaceuticals LP ($129.11) |
| 2021 | $703.57 | 44 | AstraZeneca Pharmaceuticals LP ($159.23) |
| 2020 | $346.02 | 23 | Novo Nordisk Inc ($74.78) |
| 2019 | $502.36 | 35 | AstraZeneca Pharmaceuticals LP ($125.79) |
| 2018 | $718.85 | 58 | Takeda Pharmaceuticals U.S.A., Inc. ($263.95) |
| 2017 | $721.30 | 47 | Janssen Pharmaceuticals, Inc ($170.22) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Neurology | ||||||
| 11/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.70 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: RESPIRATORY | ||||||
| 04/01/2024 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Respiratory | ||||||
| 01/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BEVESPI AEROSPHERE | Food and Beverage | In-kind items and services | $169.55 | General |
| Category: Respiratory | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 08/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2023 | Metacel Pharmaceuticals LLC | Ozobax (Drug) | Food and Beverage | Cash or cash equivalent | $8.92 | General |
| Category: Neurology | ||||||
| 08/08/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: RESPIRATORY | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 493 | 2,262 | $184,575 | $105,900 |
| 2022 | 5 | 551 | 2,161 | $181,780 | $93,303 |
| 2021 | 5 | 575 | 2,309 | $195,555 | $103,967 |
| 2020 | 9 | 766 | 2,808 | $231,140 | $104,320 |
Total Patients
2,385
Total Services
9,540
Medicare Billing
$407,490
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 295 | 914 | $91,350 | $46,491 | 50.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 80 | 575 | $43,125 | $28,728 | 66.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 680 | $40,800 | $25,373 | 62.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 51 | $5,100 | $3,040 | 59.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $2,625 | $1,325 | 50.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 21 | $1,575 | $943.33 | 59.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 356 | 1,020 | $101,975 | $50,488 | 49.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 93 | 584 | $43,800 | $25,077 | 57.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 38 | 488 | $29,280 | $14,242 | 48.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 40 | $4,000 | $2,110 | 52.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 16 | 18 | $1,350 | $880.67 | 65.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,375 | $506.05 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 376 | 1,153 | $115,300 | $61,089 | 53.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 59 | 638 | $38,280 | $18,753 | 49.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 68 | 406 | $30,450 | $17,946 | 58.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 59 | 99 | $9,900 | $5,430 | 54.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $1,625 | $748.85 | 46.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 430 | 1,274 | $127,400 | $50,480 | 39.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 76 | 872 | $52,320 | $25,332 | 48.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 61 | 420 | $31,500 | $18,359 | 58.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 77 | 115 | $11,500 | $6,070 | 52.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 19 | 23 | $1,725 | $1,173 | 68.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 12 | 13 | $1,625 | $755.09 | 46.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 32 | 32 | $640.00 | $626.56 | 97.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 17 | 17 | $2,125 | $608.51 | 28.6% |
About Dr. Martin Grotheer, M.D
Dr. Martin Grotheer, M.D is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750352597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Martin Grotheer, M.D has received a total of $4,098 in payments from pharmaceutical and medical device companies, with $351.36 received in 2024. These payments were reported across 246 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($4,087).
As a Medicare-enrolled provider, Grotheer has provided services to 2,385 Medicare beneficiaries, totaling 9,540 services with total Medicare billing of $407,490. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 01/30/2006
- Last Updated 11/09/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750352597
Products in Payments
- FARXIGA (Drug) $419.80
- AIRSUPRA (Drug) $354.24
- Trintellix (Drug) $342.98
- TRELEGY ELLIPTA (Drug) $331.06
- XARELTO (Drug) $247.41
- LONHALA MAGNAIR (Drug) $165.38
- SYMBICORT (Drug) $149.43
- GVOKE PFS (Drug) $138.86
- Ozempic (Drug) $137.81
- ENTRESTO (Drug) $133.46
- VRAYLAR (Drug) $130.55
- BREO (Drug) $116.19
- JANUVIA (Drug) $115.65
- Dexilant (Drug) $114.70
- REXULTI (Drug) $73.26
- STIOLTO RESPIMAT (Drug) $71.90
- SOLIQUA (Drug) $57.43
- AREXVY (Drug) $54.89
- VIBERZI (Drug) $49.03
- UTIBRON (Drug) $48.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Family Medicine $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Family Medicine $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Family Medicine $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Family Medicine $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Family Medicine $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261
Family Medicine $121,261